Cargando…

Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19

Detalles Bibliográficos
Autores principales:	Gade, Akhil R., Alavala, Harshitha, Allam, Sridhar R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society of Nephrology. Published by Elsevier Inc. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340591/ https://www.ncbi.nlm.nih.gov/pubmed/32650019 http://dx.doi.org/10.1016/j.kint.2020.06.025

Ejemplares similares

Interleukin-6 blockade with tocilizumab in COVID-19: Does it live up to its hype?
por: Kow, C.S., et al.
Publicado: (2021)

Tocilizumab administration in a refractory case of COVID-19
por: Dastan, Farzaneh, et al.
Publicado: (2020)

A Rare Adverse Event after CoronaVac(®)Administration: Neutropenia in a Kidney Transplant Recipient
por: Artan, Ayşe Serra, et al.
Publicado: (2022)

Interleukin-6 Antagonist Tocilizumab to Treat Critically Ill Coronavirus Disease 2019 Patients With Cytokine Release Syndrome: A Case Series
por: Yang, Stephen Su, et al.
Publicado: (2021)

Adnexal torsion in an adolescent renal transplant recipient
por: Mishra, V. V., et al.
Publicado: (2016)

Re: Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM
por: Klopfenstein, Timothée, et al.
Publicado: (2022)

Tuberculosis in renal transplant recipient
por: Kalita, P., et al.
Publicado: (2010)

Use of the interleukin 6 inhibitor tocilizumab in Japanese patients with cytokine release syndrome caused by COVID-19-related acute respiratory distress syndrome: A case series
por: Nakamura, Hideta, et al.
Publicado: (2020)

‘Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM’ – Author's reply
por: Broman, Niklas, et al.
Publicado: (2022)

High levels of TNFα in patients with COVID-19 refractory to tocilizumab
por: Danlos, F.X., et al.
Publicado: (2021)

Increased serum interleukin-6 levels in patients with hidradenitis suppurativa
por: Xu, Haoxiang, et al.
Publicado: (2017)

Oral manifestations in liver transplant recipients
por: Shanbhag, Vagish Kumar Laxman
Publicado: (2015)

Tocilizumab in severe COVID-19
por: Lucio Liberato, Nicola, et al.
Publicado: (2020)

Tocilizumab and soluble interleukin-6 receptor in JAK2V617F somatic mutation and myeloproliferative neoplasm
por: Pedersen, Kasper Mønsted, et al.
Publicado: (2020)

Donor's Versus Recipient's Demographic Data for Estimating Kidney Function in Kidney Transplant Recipients
por: Nabiee, Morteza, et al.
Publicado: (2019)

Tocilizumab in a Child with Acute Leukoencephalopathy with Restricted Diffusion
por: Jaiswal, Anshul, et al.
Publicado: (2023)

Bioequivalence study of cyclosporine in renal transplant recipients
por: Gautam, Gagan
Publicado: (2007)

BK Virus and Nephropathy in Kidney Transplant Recipients
por: Einollahi, B., et al.
Publicado: (2016)

New Biomarker of Preeclampsia in Kidney Transplant Recipients
por: Noda, Ryunosuke, et al.
Publicado: (2022)

Nocardiosis in a renal transplant recipient following rituximab preconditioning
por: Flohr, Tanya R, et al.
Publicado: (2009)

Improvements in Intractable Lumbar and Lower-Extremity Symptoms after Systemic Administration of Tocilizumab, an Anti-interleukin-6 Receptor Antibody
por: Sainoh, Takeshi, et al.
Publicado: (2022)

Cytomegalovirus Viremia, Pneumonitis, and Tocilizumab Therapy
por: van Duin, David, et al.
Publicado: (2011)

Interleukin-6 level, right ventricular systolic dysfunction, and coronavirus disease 2019
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration
por: Benotmane, Ilies, et al.
Publicado: (2022)

Isolated Epidermolytic Acanthoma in a Renal Transplant Recipient
por: Yang, Ji-Hye, et al.
Publicado: (2011)

Urinary Tract Abscess in Nephrectomized Renal Transplant Recipient
por: Afshar, Reza, et al.
Publicado: (2009)

Renal cortical necrosis in a renal transplant recipient
por: Eswarappa, M., et al.
Publicado: (2013)

Sepsis in heart transplant recipients: Is the new definition applicable?
por: Singh, Sarvesh Pal
Publicado: (2016)

Strongyloid Hyperinfection Syndrome in a Renal Transplant Recipient
por: Sriperumbuduri, S., et al.
Publicado: (2017)

COVID-19 reinfection in a kidney transplant recipient
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

COVID-19 reinfection in a kidney transplant recipient
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Super-fast-track discharge of liver transplant recipients
por: Verma, Sapana, et al.
Publicado: (2023)

Anesthetic concerns in recipients of hematopoietic stem cell transplant
por: Chowdhury, Sumit Roy, et al.
Publicado: (2023)

Tocilizumab, Adipokines and Severe Complications of COVID-19
por: Fioravanti, Antonella, et al.
Publicado: (2020)

Skin cancer diagnosis in renal transplant recipients during the Covid‐19 pandemic
por: Keeling, E., et al.
Publicado: (2022)

Asymptomatic and symptomatic respiratory virus infection detected in naso-pharyngeal swabs from solid organ transplant recipients early after transplantation
por: BenMarzouk-Hidalgo, Omar J., et al.
Publicado: (2011)

Anaesthesia for non-cardiac surgery in a cardiac transplant recipient
por: Gómez-Ríos, Manuel Á
Publicado: (2012)

Disseminated Tuberculosis Involving Allograft in a Renal Transplant Recipient
por: Sutariya, Harsh C., et al.
Publicado: (2016)

A rare but life-threatening complication in liver transplant recipients
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2015)

Recurrent neutropenia induced by rifabutin in a renal transplant recipient
por: Chang, Ji Yeun, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8bhh2tmjfrrov4ktl4n50j46vi